Low doses of methylnaltrexone inhibits head and neck squamous cell carcinoma growth in vitro and in vivo by acting on the mu‐opioid receptor
Year: 2021
Type: article
Source: Journal of Cellular Physiology
DOI: 10.1002/jcp.30421
Language: English
Subfield: Psychiatry and Mental health
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Award: G2045996051
OpenAlex ID: W3164543103
